Invokana 100 MG Oral Tablet

RxCUI
1373469
RxNorm name
Invokana 100 MG Oral Tablet
Display name
Invokana 100 MG Oral Tablet
Full name
Invokana 100 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:18

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
INVOKANACANAGLIFLOZINJanssen Pharmaceuticals, Inc.b9057d3b-b104-4f09-8a61-c61ef9d4a3f32026-06-11Warnings, Adverse reactionsExact identifier
rxcui: 1373469
INVOKANACANAGLIFLOZINCardinal Health 107, LLC5f76e16f-0c24-454a-81af-4080b312c9402026-02-17Warnings, Adverse reactionsExact identifier
rxcui: 1373469
INVOKANACANAGLIFLOZINA-S Medication Solutions8d5f892b-e4f3-4a9e-9a91-95e2fca341442023-12-15Warnings, Adverse reactionsExact identifier
rxcui: 1373469

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
b9057d3b-b104-4f09-8a61-c61ef9d4a3f3Invokana 100 MG Oral TabletPSN31These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 201320250320
b9057d3b-b104-4f09-8a61-c61ef9d4a3f3canagliflozin 100 MG Oral Tablet [Invokana]SBD31These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 201320250320
b9057d3b-b104-4f09-8a61-c61ef9d4a3f3Invokana 100 MG Oral TabletSY31These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 201320250320
5f76e16f-0c24-454a-81af-4080b312c940Invokana 100 MG Oral TabletPSN14These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 201320260217
5f76e16f-0c24-454a-81af-4080b312c940Invokana 100 MG Oral TabletSY14These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 201320260217
5f76e16f-0c24-454a-81af-4080b312c940canagliflozin 100 MG Oral Tablet [Invokana]SBD14These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 201320260217
8d5f892b-e4f3-4a9e-9a91-95e2fca34144Invokana 100 MG Oral TabletSY9These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 201320231215
8d5f892b-e4f3-4a9e-9a91-95e2fca34144canagliflozin 100 MG Oral Tablet [Invokana]SBD9These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 201320231215
8d5f892b-e4f3-4a9e-9a91-95e2fca34144Invokana 100 MG Oral TabletPSN9These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 201320231215